RSS-Feed abonnieren
DOI: 10.1055/s-2006-950433
Introduction of the Acetate Unit to the 2-Pyridinone Ring System and Its Application to the Synthesis of (20S)-Camptothecin DE Ring System
Publikationsverlauf
Publikationsdatum:
22. September 2006 (online)
Abstract
The DE ring system of (20S)-camptothecin had been prepared from commercially available nicotinic acid in six steps utilizing the nucleophilic addition reaction of the silyl ketene acetal to the pyridinone ring as a key step.
Key words
anti-tumor agents - asymmetric synthesis - Lewis acids - nucleophilic additions - regioselectivity
-
1a
Kumar R.Chandra R. In Advances in Heterocyclic Chemistry Vol. 78:Katritzky AR. Academic Press; San Diego: 2001. p.269 -
1b
Lavilla R. J. Chem. Soc., Perkin Trans. 1 2002, 1141 - 2
Comins DL.Joseph SP. In Comprehensive Heterocyclic Chemistry II Vol. 5:Katritzky AR.Rees CW.Scriven EFV. Pergamon; Oxford: 1996. p.37 -
3a
Kuethe JT.Comins DL. J. Org. Chem. 2004, 69: 5219 -
3b
Comins DL.Sahn JJ. Org. Lett. 2005, 7: 5227 ; and references cited therein - 4
Afarinkia K.Vinader V.Nelson TD.Posner GH. Tetrahedron 1992, 48: 9111 -
5a
Posner GH.Switzer C. J. Org. Chem. 1987, 52: 1642 -
5b
Posner GH.Vinader V.Afarinkia K. J. Org. Chem. 1992, 57: 4088 -
5c
Afarinkia K.Mahmood F. Tetrahedron Lett. 1998, 39: 493 ; and references cited therein - 6
Kuethe JT.Comins DL. Org. Lett. 1999, 1: 1031 -
7a
Hiroya K.Jouka R.Kameda M.Yasuhara A.Sakamoto T. Tetrahedron 2001, 57: 9697 -
7b
Hiroya K.Matsumoto S.Sakamoto T. Org. Lett. 2004, 6: 2953 -
7c
Inamoto K.Katsuno M.Yoshino T.Suzuki I.Hiroya K.Sakamoto T. Chem. Lett. 2004, 33: 1026 -
7d
Hiroya K.Itoh S.Sakamoto T. Tetrahedron 2005, 61: 10958 -
7e
Hiroya K.Matsumoto S.Ashikawa M.Kida H.Sakamoto T. Tetrahedron 2005, 61: 12330 -
7f
Inamoto K.Yamamoto A.Ohsawa K.Hiroya K.Sakamoto T. Chem. Pharm. Bull. 2005, 53: 1502 - 8
Hiroya K.Jouka R.Katoh O.Sakuma T.Anzai M.Sakamoto T. Arkivoc 2003, (viii): 232 - 9
Wall ME.Wani MC.Cook CE.Palmer KH.McPhail AT.Sim GA. J. Am. Chem. Soc. 1966, 88: 3888 - Camptothecin had been isolated from other sources, see:
-
10a
Das B.Madhusudhan P.Reddy PV.Anitha Y. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 2001, 40: 453 -
10b
Kitajima M.Yoshida S.Yamagata K.Nakamura M.Takayama H.Saito K.Seki H.Aimi N. Tetrahedron 2002, 58: 9169 -
10c
Puri SC.Verma V.Amna T.Qazi GN.Spiteller M. J. Nat. Prod. 2005, 68: 1717 - 11
Stork G.Schultz AG. J. Am. Chem. Soc. 1971, 93: 4074 - 12
Corey EJ.Crouse DN.Anderson JE. J. Org. Chem. 1975, 40: 2140 - 13
Hsiang Y.-H.Hertzberg R.Hecht S.Liu LF. J. Biol. Chem. 1985, 260: 14873 - For reviews on the synthesis of camptothecin and its analogues, see:
-
14a
Du W. Tetrahedron 2003, 59: 8649 -
14b
Thomas CJ.Rahier NJ.Hecht SM. Bioorg. Med. Chem. 2004, 12: 1585 - For the synthesis of camptothecin since the publications of ref. 14, see:
-
15a
Twin H.Batey RA. Org. Lett. 2004, 6: 4913 -
15b
Chavan SP.Pasupathy K.Venkatraman MS.Kale RR. Tetrahedron Lett. 2004, 45: 6879 -
15c
Yu JR.DePue J.Kronenthal D. Tetrahedron Lett. 2004, 45: 7247 -
15d
Chavan SP.Venkatraman MS. Arkivoc 2005, (iii): 165 -
15e
Anderson RJ.Raolji GB.Kanazawa A.Greene AE. Org. Lett. 2005, 7: 2989 - 16
Comins DL.Nolan JM. Org. Lett. 2001, 3: 4255 - 17
Peters R.Althaus M.Nagy A.-L. Org. Biomol. Chem. 2006, 4: 498 - 18
Shi X.-X.Dai L.-X. J. Org. Chem. 1993, 58: 4596 - 19
Tagami K.Nakazawa N.Sano S.Nagao Y. Heterocycles 2000, 53: 771 -
20a
Towson JC.Weismiller MC.Lal GS.Sheppard AC.Kumar A.Davis FA. Org. Synth. 1990, 69: 158 -
20b
Davis FA.Weismiller MC. J. Org. Chem. 1990, 55: 3715 -
20c
Davis FA.Kumar A.Chen B.-C. Tetrahedron Lett. 1991, 32: 867 -
20d
Davis FA.Weismiller MC.Murphy CK.Reddy RT.Chen B.-C. J. Org. Chem. 1992, 57: 7274 -
20e
Chen B.-C.Murphy CK.Kumar A.Reddy RT.Clark C.Zhou P.Lewis BM.Gala D.Mergelsberg I.Scherer D.Buckley J.DiBenedetto D.Davis FA. Org. Synth. 1996, 73: 159 -
21a
Verfürth U.Herrmann R. J. Chem. Soc., Perkin Trans. 1 1990, 2919 -
21b
Page PCB.Heer JP.Bethell D.Lund A.Collington EW.Andrews DM. J. Org. Chem. 1997, 62: 6093
References and Notes
Asymmetric Hydroxylation of 19 by 20c (Table [3] , entry 3): KHMDS (0.79 mL, 0.59 mmol, 0.75 M solution in toluene) was slowly added to a solution of 19 (152 mg, 0.536 mmol) in anhyd THF (6.0 mL) at -78 °C. After stirring for 30 min, a solution of 20c (240 mg, 0.829 mmol) in anhyd THF (6.0 mL) was slowly added to the reaction mixture at -78 °C and stirred for 5 h at the same temperature. A sat. aq solution of NH4Cl and THF were added successively to the mixture and the dry ice-acetone bath was removed. H2O was added to the mixture and the aqueous phase was extracted with EtOAc. The combined organic solution was washed with a sat. aq solution of Na2SO3 and brine, dried over anhyd MgSO4, and concentrated. The residue was purified by silica gel chromatography [EtOAc-hexane (2:3)] to afford (S)-21 (133 mg, 83%, 72% ee) as a white solid; mp 140 °C (benzene); [α]D 23 +107.2 (c 1.01, CHCl3, 91% ee). IR (film): 3362, 1747, 1651, 1593, 1564, 1229, 1139, 1047, 880, 748, 702 cm -1. 1H NMR (400 MHz, CDCl3): δ = 0.96 (3 H, t, J = 7.2 Hz), 1.71-1.87 (2 H, m), 3.65 (1 H, s), 5.11 (1 H, d, J = 14.4 Hz), 5.18 (2 H, m), 5.61 (1 H, d, J = 16.0 Hz), 6.50 (1 H, d, J = 7.2 Hz), 7.20-7.45 (6 H, m). 13C NMR (100 MHz, CDCl3): δ = 7.7, 31.6, 52.3, 66.6, 72.1, 102.9, 119.0, 128.2, 128.3, 128.9, 135.5, 137.4, 148.3, 158.6, 173.7. MS: m/z (%) = 299 (M+, 88.8), 270 (20.6), 164 (17.8), 91 (100.0). HRMS: m/z calcd for C17H17NO4: 299.1157; found: 299.1138. Anal. Calcd for C17H17NO4: C, 68.21; H, 5.72; N, 4.68. Found: C, 68.07; H, 5.79; N, 4.59.
23The ee was determined by chiral HPLC (Daicel, Chiralcel OD-H, EtOH-hexane, 1:9).